NEW YORK (GenomeWeb News) – Evogene on Friday reported a spike in its year-over-year revenues and net loss.
 
The Rehovot, Israel-based agricultural genomics firm reported revenues of $870,000 for the three-month period ended Sept. 30, compared to $39,000 for the third quarter of 2007. The most recent quarter’s results include revenue from the firm’s recently signed collaboration with Monsanto.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.